These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15372206)

  • 1. Immunotherapy at the American Association for Cancer Research 95th annual meeting: a personal impression.
    Guinn BA
    Cancer Immunol Immunother; 2005 Mar; 54(3):290-5. PubMed ID: 15372206
    [No Abstract]   [Full Text] [Related]  

  • 2. Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.
    Kloke BP; Rae R; Mahr A; Burkhardt UE; Kvistborg P; Britten CM
    Cancer Immunol Immunother; 2014 Jul; 63(7):749-55. PubMed ID: 24190545
    [No Abstract]   [Full Text] [Related]  

  • 3. Ninth annual meeting of the Association for Cancer Immunotherapy (CIMT 2011), May 25-27, 2011, Mainz, Germany.
    Hobohm K; Seppmann T; Britten CM; Hoff H
    Cancer Immunol Immunother; 2012 Jan; 61(1):137-43. PubMed ID: 22048716
    [No Abstract]   [Full Text] [Related]  

  • 4. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 5. Toward next-generation cancer immunotherapy: 10th annual meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 23-25, 2012.
    Kloke BP; Kutscher S; Rae R; Kvistborg P; Britten CM; Hadrup SR
    Cancer Immunol Immunother; 2013 May; 62(5):975-81. PubMed ID: 23299564
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.
    Kloke BP; Mahr A; Jabulowsky RA; Kutscher S; Rae R; Britten CM
    Cancer Immunol Immunother; 2015 Jul; 64(7):923-30. PubMed ID: 25548093
    [No Abstract]   [Full Text] [Related]  

  • 7. Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011.
    Martinez Forero I; Okada H; Topalian SL; Gajewski TF; Korman AJ; Melero I
    J Transl Med; 2012 May; 10():108. PubMed ID: 22640522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of efficacy in cancer immunotherapy: 14th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 10-12, 2016.
    Theelen J; Braun J; Hörzer H; Kloke BP; Ott M; Pizzitola I; Schirmer U; Miller M
    Cancer Immunol Immunother; 2017 May; 66(5):673-681. PubMed ID: 28251274
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer vaccines.
    Chekhun VF
    Exp Oncol; 2008 Jun; 30(2):90. PubMed ID: 18680872
    [No Abstract]   [Full Text] [Related]  

  • 10. CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.
    Diken M; Attig S; Grunwitz C; Kranz L; Simon P; van de Roemer N; Vascotto F; Kreiter S
    Hum Vaccin Immunother; 2013 Sep; 9(9):2025-32. PubMed ID: 23877042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell vaccination and other strategies to tip the balance of the immune system : DC2007 5th International Meeting, July 16-18, Bamberg, Germany.
    Schaft N; Birkholz K; Hofmann C; Schmid M; Theiner G; Dörrie J
    Cancer Immunol Immunother; 2008 Jun; 57(6):913-28. PubMed ID: 18236041
    [No Abstract]   [Full Text] [Related]  

  • 12. CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.
    Kranz LM; Beck JD; Grunwitz C; Hotz C; Vormehr M; Diken M
    Hum Vaccin Immunother; 2017 Oct; 13(10):2272-2279. PubMed ID: 28846471
    [No Abstract]   [Full Text] [Related]  

  • 13. Harnessing the power of the immune system to target cancer.
    Lizée G; Overwijk WW; Radvanyi L; Gao J; Sharma P; Hwu P
    Annu Rev Med; 2013; 64():71-90. PubMed ID: 23092383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines for cancer.
    Shaw DR; Strong TV
    Front Biosci; 2006 Jan; 11():1189-98. PubMed ID: 16146806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell vaccines.
    Thompson PL; Dessureault S
    Adv Exp Med Biol; 2007; 601():345-55. PubMed ID: 17713023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report on the sixth annual meeting of the Association for Immunotherapy of Cancer (CIMT), May 15 and 16, 2008 in Mainz, Germany.
    Welters MJ; van Montfoort N; Khan S; Meyer RG; Britten CM
    Cancer Immunol Immunother; 2009 May; 58(5):777-87. PubMed ID: 18982325
    [No Abstract]   [Full Text] [Related]  

  • 17. Personalized dendritic cell-based tumor immunotherapy.
    Janikashvili N; Larmonier N; Katsanis E
    Immunotherapy; 2010 Jan; 2(1):57-68. PubMed ID: 20161666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the innate and adaptive immune responses against cancer: 95th AACR meeting 2004.
    Finn OJ
    Cancer Immunol Immunother; 2005 Mar; 54(3):287-9. PubMed ID: 15517257
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings of the 7th Annual Meeting of the Society of Biotherapeutic Approaches and the 2nd Annual Meeting of the Japan Research Association for Immunotherapeutics. December 7, 2003. Tokyo, Japan.
    Anticancer Res; 2004; 24(5C):3289-392. PubMed ID: 15529466
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunology and immunotherapy of human cancer: present concepts and clinical developments.
    Bremers AJ; Parmiani G
    Crit Rev Oncol Hematol; 2000 Apr; 34(1):1-25. PubMed ID: 10781746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.